Sagimet Biosciences Inc. (SGMT) Profit Margin
Sagimet Biosciences Inc. (SGMT) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -1393.80% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How SGMT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| GOSS | Gossamer Bio Inc. | -351.49% |
| KURA | Kura Oncology Inc. | -412.95% |
| VSTM | Verastem Inc. | -677.59% |
| AGIO | Agios Pharmaceuticals Inc. | -764.01% |
| DMAC | DiaMedica Therapeutics Inc. | -1146.80% |
These are five companies in the same sector as SGMT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sagimet Biosciences Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("SGMT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SGMT | $10.18 | +0.00% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |